
Paul Karpecki joins Freedom Meditech Scientific Advisory Board
pharmafile | June 13, 2013 | Appointment | Manufacturing and Production, Research and Development, Sales and Marketing |Â Â Freedom meditechÂ
Medical device company Freedom Meditech has appointed Dr Paul Karpecki to its Scientific Advisory Board.
Karpecki currently works in corneal services, heads the ocular surface disease clinic and is director of clinical research at the Koffler Vision Group in Lexington, Kentucky, US.
Karpecki was one of two optometrists appointed to the Delphi International Society at Wilmer-Johns Hopkins, which included the top 25 dry eye experts in the world, and the National Eye Institute’s Dry Eye Committee to provide insights around dry eye and women.
A noted educator and author, Karpecki is the chief medical editor and vice president of clinical content for the Review of Optometry Journal. He also serves on the board for the charitable organisation Optometry Giving Sight.
Karpecki said: “I am joining the scientific advisory board at an exciting time for the company as it prepares to introduce optometrists to ClearPath DS-120. Detecting autofluorescence in the crystalline lens of the eye, which has been tied to biomarkers associated with diabetes, represents an important and valuable new health offering optometrists can consider during an eye exam.”






